Shared compound evidence record
CJC-1295 (no DAC) + Ipamorelin (10mg)
GH-Signalling Research
Loading the shop...
In Stock
CJC-1295 (10mg)
no DAC Lyophilised Powder
For laboratory research only.
Early Black Friday: 20% off. Automatically applied.
Quantity
1 vial
1
Buying more? Save up to 15%
Item total$67.19
Standard delivery$9.99
This selection, delivered$77.18AUD
Or choose express delivery for $15.99.
Estimate for these items only, before discount codes or payment fees. Final total in checkout.
No account needed · PayID / bank transfer
Analytical documentation
View published lab report99.488% / 99.475% purity reported
Catalogue-associated report; current inventory-lot match is not established. Confirm before relying on it.
Labelled quantity
10mg
Category
GH-Signalling Research
Next business day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
12:24:39
Dispatch follows payment confirmation. Delivery options and cutoff terms
Most Popular Peptides
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Shared compound evidence record
CJC-1295 with DAC (10mg)
GH-Signalling Research
Connected compound evidence
Ipamorelin (10mg)
GH-Signalling Research
Connected compound evidence
Retatrutide (10mg)
Metabolic Research
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
CJC-1295 (no DAC) (10mg): laboratory research material
This material is listed under the catalogue designation CJC-1295 (no DAC). Preserve the no-DAC distinction when comparing GHRH-related peptide materials and request exact structural documentation for the sample.
Presentation and analytical documentation
Supplied as a lyophilised powder. The product name states the nominal quantity for this catalogue format. Review the analytical-document status and the CoA library for available sample reports. Read the identifiers, methods and measured results in the actual report; do not assume that one record covers every vial or batch.
Research context
No. The listings describe different material designations. Evidence about a DAC-containing molecule should not be transferred to a no-DAC product without confirming structure and study-material identity. Consult the CJC-1295 (no DAC) research guide for source context and evidence limits.
Laboratory preparation and storage
Use the material-specific documentation and a validated laboratory method to select solvent, concentration and storage conditions. Keep the sample identifier and preparation record with the experimental data. A labelled mass or purity result does not establish solution stability, sterility or suitability for a particular assay.
For laboratory research only. Not for human or veterinary use.
Frequently Asked Questions
What is CJC-1295 (no DAC)?
This material is listed under the catalogue designation CJC-1295 (no DAC). Preserve the no-DAC distinction when comparing GHRH-related peptide materials and request exact structural documentation for the sample.
